MML Investors Services LLC boosted its holdings in shares of Healthpeak Properties, Inc. (NYSE:PEAK – Get Rating) by 10.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 87,367 shares of the company’s stock after purchasing an additional 8,120 shares during the quarter. MML Investors Services LLC’s holdings in Healthpeak Properties were worth $2,002,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of PEAK. EverSource Wealth Advisors LLC raised its stake in shares of Healthpeak Properties by 270.8% in the third quarter. EverSource Wealth Advisors LLC now owns 1,294 shares of the company’s stock valued at $30,000 after acquiring an additional 945 shares during the period. ING Groep NV raised its stake in shares of Healthpeak Properties by 20.3% in the second quarter. ING Groep NV now owns 103,911 shares of the company’s stock valued at $2,692,000 after acquiring an additional 17,506 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its stake in shares of Healthpeak Properties by 31.6% in the second quarter. Tokio Marine Asset Management Co. Ltd. now owns 8,309 shares of the company’s stock valued at $215,000 after acquiring an additional 1,994 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Healthpeak Properties by 213.7% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 193,336 shares of the company’s stock valued at $5,009,000 after acquiring an additional 131,710 shares during the period. Finally, Rhumbline Advisers raised its stake in shares of Healthpeak Properties by 9.1% in the second quarter. Rhumbline Advisers now owns 951,243 shares of the company’s stock valued at $24,647,000 after acquiring an additional 79,524 shares during the period. Hedge funds and other institutional investors own 92.04% of the company’s stock.
Healthpeak Properties Stock Down 0.9 %
Shares of Healthpeak Properties stock opened at $24.33 on Tuesday. The company has a debt-to-equity ratio of 0.90, a current ratio of 0.72 and a quick ratio of 0.72. Healthpeak Properties, Inc. has a 1 year low of $21.41 and a 1 year high of $35.72. The firm’s 50-day moving average is $26.26 and its two-hundred day moving average is $25.42. The stock has a market cap of $13.30 billion, a price-to-earnings ratio of 26.45, a PEG ratio of 3.59 and a beta of 0.88.
Healthpeak Properties Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 23rd. Stockholders of record on Thursday, February 9th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 4.93%. The ex-dividend date was Wednesday, February 8th. Healthpeak Properties’s payout ratio is currently 130.44%.
Insider Transactions at Healthpeak Properties
In other news, Director Christine Garvey sold 1,000 shares of Healthpeak Properties stock in a transaction that occurred on Tuesday, December 27th. The shares were sold at an average price of $25.11, for a total value of $25,110.00. Following the transaction, the director now owns 23,827 shares of the company’s stock, valued at approximately $598,295.97. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.28% of the company’s stock.
Analyst Ratings Changes
Several brokerages have recently weighed in on PEAK. TheStreet downgraded shares of Healthpeak Properties from a “b-” rating to a “c+” rating in a research note on Tuesday, February 21st. Barclays reduced their target price on shares of Healthpeak Properties from $34.00 to $33.00 and set an “overweight” rating on the stock in a research note on Friday, February 10th. Royal Bank of Canada downgraded shares of Healthpeak Properties from an “outperform” rating to a “sector perform” rating and reduced their price target for the stock from $35.00 to $28.00 in a research note on Wednesday, December 14th. Jefferies Financial Group raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price target for the stock from $23.00 to $29.00 in a research note on Monday, January 2nd. Finally, Evercore ISI raised shares of Healthpeak Properties from an “in-line” rating to an “outperform” rating and set a $28.00 price target on the stock in a research note on Monday, November 21st. Six equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $30.18.
Healthpeak Properties Profile
Healthpeak Properties, Inc is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community (CCRC). The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry.
Featured Articles
- Get a free copy of the StockNews.com research report on Healthpeak Properties (PEAK)
- Reserve Your Spot With These Hotels The Analysts Support
- Cruise Line Stocks Still Have Some Choppy Waters to Navigate
- Four Vegan Food Stocks Performing Beyond the Norm
- Ocean Interest Electrifies Fisker Stock
- Is Freshpet Ready For A Fresh Rally?
Want to see what other hedge funds are holding PEAK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:PEAK – Get Rating).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.